Clinical Trials Directory

Trials / Completed

CompletedNCT02721758

Understanding and Promoting Health Behaviour Change Amid Transition to Cardiac Rehabilitation

Design and Evaluation of a Brief Motivational Intervention to Promote Enrolment in Outpatient Cardiac Rehabilitation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to test whether a brief motivational intervention is associated with enrollment in cardiac rehabilitation.

Detailed description

Cardiac rehabilitation programs help reduce morbidity and mortality following a cardiac event, but only a subset of referred patients chooses to participate. An intervention based on principles of motivational interviewing may help resolve individuals' ambivalence about cardiac rehabilitation. The primary aim is to evaluate the efficacy of a brief motivational intervention (MI) for enhancing intention to enroll in cardiac rehabilitation compared to a usual care (UC) control condition among patients referred to cardiac rehabilitation. It is hypothesized that patients in the MI condition will report greater intention to enroll in cardiac rehabilitation compared to patients in UC. A small-scale feasibility trial will include patients (n = 100) with acute coronary syndrome who are referred to a standard 12-week exercise-based cardiac rehabilitation program in Calgary, Canada. Patients will be randomly assigned to MI or UC. The primary outcome will be self-reported intention to attend cardiac rehabilitation. Secondary outcomes will include beliefs about cardiac rehabilitation, exercise self-efficacy, perceived barriers, and cardiac rehabilitation enrollment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief Motivational Intervention

Timeline

Start date
2015-06-01
Primary completion
2016-05-01
Completion
2017-04-01
First posted
2016-03-29
Last updated
2022-05-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02721758. Inclusion in this directory is not an endorsement.